English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/143305
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Effect of a ropy Exopolysaccharide-producing Bifidobacterium animalis subsp. Lactis strain orally administered on dss-induced colitis mice model

AuthorsHidalgo-Cantabrana, Claudio ; Algieri, Francesca; Rodriguez-Nogales, Alba; Vezza, Teresa; Martínez-Camblor, Pablo; Margolles Barros, Abelardo ; Ruas-Madiedo, Patricia ; Gálvez, Julio
Immune modulation
Mouse model
Issue Date9-Jun-2016
PublisherFrontiers Media
CitationFrontiers in Microbiology 7: 868 (2016)
AbstractExopolysaccharide (EPS)-producing bifidobacteria, particularly Bifidobacterium animalis subsp. lactis strains, are used in the functional food industry as promising probiotics with purported beneficial effects. We used three isogenic strains of B. animalis subsp. lactis, with different EPS producing phenotypes (mucoid-ropy and non-ropy), in order to determine their capability to survive the murine gastrointestinal tract transit, as well as to evaluate their role in improving clinical outcomes in a chemically-induced colitis model. The three strains were able to survive in the intestinal tract of C57BL/6J mice during the course of the intervention study. Furthermore, the disease activity index (DAI) of the animal group treated with the ropy strain was significantly lower than of the DAI of the placebo group at the end of the treatment. However, no significant differences were found among the three strains. The analysis of several immune parameters, such as TNFα and IL-10 quantified in blood plasma and lymphocyte populations enumerated in mesenteric nodes, showed some significant variations among the four experimental animal groups. Remarkably, a higher capability of the ropy strain to increase regulatory T-cells in mesenteric lymphoid nodes was demonstrated, suggesting a higher ability of this strain to regulate inflammatory responses at mucosal level. Our data indicate that strains of B. animalis subsp. lactis producing EPS that confer a mucoid-ropy phenotype could represent promising candidates to perform further studies targeting intestinal inflammatory processes.
Publisher version (URL)https://doi.org/10.3389/fmicb.2016.00868
Identifiersissn: 1664-302X
Appears in Collections:(IPLA) Artículos
Files in This Item:
File Description SizeFormat 
Ropy Exopolysaccharide-Hidalgo-Cantabrana.pdf1,23 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.